Our results also indicate overexpressed Rab11-FIP2 contributes to tumor angiogenesis through PAI-1 mediation, and combined targeting of Rab11-FIP2 and PAI-1 can control tumor angiogenesis in CRC. Here, RAB11A is linked to colorectal carcinoma.